MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/10781552251331601

Медицинская библиотека · Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners · 2025

Venotoclax associated hypothyroidism in a patient with acute myeloid leukemia.

Can İzlimek Uğur, Karagün Barış, Gürkan Emel

СтатьяКлинический случайПеревод в очереди

Аннотация

IntroductionVenetoclax is a selective inhibitor of BCL2. While its combination with hypomethylating agents (HMAs) is associated with manageable side effects, thyroid dysfunction has not been previously reported.Case ReportWe present the case of a 62-year-old female with relapsed/refractory AML who was treated with azacitidine and venetoclax. Within a month, she developed hypothyroidism with elevated TSH (42.86 µIU/mL) and low FT4 (0.34 ng/dL). Baseline thyroid function tests were normal.Management & OutcomeUltrasonography showed a diffusely enlarged thyroid gland, and thyroid autoantibodies were negative, ruling out autoimmune thyroiditis.Thyroid hormone replacement therapy was initiated, normalizing thyroid function, while venetoclax was continued due to its efficacy.DiscussionThis case highlights a rare, non-autoimmune thyroid dysfunction associated with venetoclax. The absence of autoantibodies suggests a mechanism unrelated to autoimmunity, emphasizing the need for thyroid monitoring during venetoclax therapy.

Для цитирования: Can İzlimek Uğur, Karagün Barış, Gürkan Emel. Venotoclax associated hypothyroidism in a patient with acute myeloid leukemia.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2025. DOI: 10.1177/10781552251331601.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.